Thursday 14 June 2012

VCs & Venture Capital Investment Company News - 14 June 2012

Highlights from the past week’s VC Investment Company news.

Heritage Group Closes Healthcare Innovation Fund at $157 Million

Heritage Group, a Nashville, Tenn.-based investment and advisory group that works with health-care companies, has raised its first formal fund, and already used it to back two privately held medical-technology providers, the group said. Heritage Healthcare Innovation Fund LP, a $157 million investment vehicle, will not just provide financial backing to start-up companies, a spokeswoman said, but will enable developers of new products to collaborate with large health-care companies, including some of the fund's limited partners.

http://pevc.dowjones.com/article?an=DJFVW00020120604e864rr14x&from=alert&pid=32&ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120604e864rr14x%26from%3dalert%26pid%3d32

Felicis Ventures Launches $70M Third Fund

Palo Alto, California-based venture capital firm Felicis Ventures has launched its $70m third fund. With the new vehicle, the firm aims to invest in mobile, e-commerce, enterprise, education, and health companies as well as explore technology areas such as 3D imaging, bio-informatics and connected devices at home.

http://www.finsmes.com/2012/06/felicis-ventures-launches-70m-fund.html 

Madrona Venture Group Announces Closing of $300 Million Fund

Madrona Venture Group (www.madrona.com) today announced that it has raised $300 million for its Fund V, with the goal of building another generation of transformational technology companies. The firm has a long history of backing highly successful technology companies, such as Amazon.com, Isilon Systems and other prominent technology companies, including Apptio, Decide.com, Impinj, Redfin, ShopIgniter and Z2Live.

http://www.madrona.com/venture-capital-team/press-release.asp?title=Madrona+Venture+Group+Announces+Closing+of+%24300+Million+Fund&release=178

This Week In Venture Capital is brought to you by VM Index from Venture Market Intelligence – Venture Capital made easier

VM Index is an online IT, Life Science, Biotech & Med Tech venture capital funding tool with expert data that enables companies to raise more money, faster and at a better valuation than they could otherwise.

Tuesday 12 June 2012

IT Venture Capital Investment News Round Up – 12 June 2012

Highlights from recent IT venture capital investment activity.

VM Index subscribers see full details of all IT Venture Capital deals from the past week plus profiles and analysis of thousands of investors and venture-backed companies.

 

June 6th, 2012 - Redwood City, CA

PubMatic Raises $45 Million in Mezzanine Financing Led by August Capital

PubMatic (www.pubmatic.com), the digital media platform for publishers, today announced that it has raised $45 million in mezzanine financing. New investor, August Capital, is leading the financing with participation from all existing investors including Draper Fisher Jurvetson, Nexus Venture Partners, Helion Ventures and Silicon Valley Bank. The funds will be used to continue PubMatic’s targeted acquisition strategy and strengthen the company’s balance sheet.

http://www.businesswire.com/news/home/20120606005885/en/PubMatic-Raises-45-Million-Mezzanine-Financing-Led 

June 4th, 2012 - Boston, MA

Gemvara Raises $25M Series D

Online fine jewelry site Gemvara Inc. has closed a $25 million round to more aggressively court and capture customers who want custom jewelry they can design themselves. Norwest Venture Partners led the Series D round-a significant bump from the $15 million Gemvara Founder Matt Lauzon initially targeted-with participation from existing investors Highland Capital Partners, Canaan Partners and Balderton Capital. 

http://pevc.dowjones.com/article?an=DJFVW00020120604e864apb2e&from=alert&pid=32&ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120604e864apb2e%26from%3dalert%26pid%3d32

June 5th, 2012 - San Francisco, CA

Identified Raises $21M

Identified Inc. has captured the interest of 20-somethings using game mechanics to build their careers. Now it's captured $21 million in venture funding. VantagePoint Capital Partners and Capricorn Investment Group co-led the Series B round, which the two-year-old company will use to triple headcount to 150 during the next 12 months as it grows its user base and then sells the data produced by those users to enterprise customers.

http://pevc.dowjones.com/article?an=DJFVW00020120605e865apkba&from=alert&pid=32&ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120605e865apkba%26from%3dalert%26pid%3d32

June 4th, 2012 - San Diego, CA

Awarepoint Raises $14 Million in Additional Funding

Awarepoint Corporation, the leading provider of real-time location system (RTLS) solutions for healthcare, today announced it raised $14 million in additional financing.  The Heritage Healthcare Innovation Fund (HHIF), a limited partnership operated by Heritage Group, a Nashville, Tenn.-based private healthcare investment firm, invested $7.5 million.  Existing investors including Kleiner Perkins Caufield & Byers, Cardinal Partners, Venrock, Jafco Ventures, Avalon Ventures, New Leaf Venture Partners and Top Tier Capital Partners invested the balance of the round.

http://www.awarepoint.com/press-release/awarepoint-raises-14-million-in-additional-funding/

June 5th, 2012 - Boston, MA

Cartera Commerce Announces $12.2 Million Growth Equity Investment

Cartera Commerce, the leading provider of card-linked marketing solutions, today announced it has raised $12.2 million in growth equity to capitalize on the massive opportunity in card-linked marketing - a market projected by analysts to exceed $1.7B by 2015. The round was led by Comvest Group and included new investments from all of Cartera's previous investors including Flybridge Capital Partners, Dace Ventures, LBO Enterprises, and Venture Capital Fund of New England.

http://www.cartera.com/newsevents/pressreleases/20120605.html

Europe

June 8th, 2012 - Munich, Germany

Westwing Receives $50M in Funding

Westwing, a Munich, Germany-based shopping club for home & living, has raised $50m in funding. The round, which brings the total amount raised to date to $82m, was led by Summit Partners, with participation from existing investors Access Industries, Holtzbrinck Ventures, Investment AB Kinnevik and Rocket Internet.

http://www.finsmes.com/2012/06/westwing-receives-50m-funding.html

June 6th, 2012 - Tel Aviv, Israel

GetTaxi Grabs $20 Million Funding

GetTaxi, an app aimed at letting people order taxis from their smartphones or via the web, has already gained significant traction in the UK, Russia and Israel. But now it has its sights set on conquering the United States — and New York City is the first on its list. So, the company is announcing today, it has raised $20 million in brand new funding to help fund its expansion efforts.

The $20 million serves as a follow-on funding round for GetTaxi, and it was led by previous investors Len Blavatnik’s Access Industries with participation by company founders Shahar Waiser and Roi More. GetTaxi, which was founded in 2010, had previously raised $11 million in outside venture capital, so this round brings its total outside funding to approximately $30 million.

http://techcrunch.com/2012/06/06/gettaxi-20-million-funding-new-york-city-us-expansion/

June 5th, 2012 - Israel

Wibbitz Raises $2.3M

Wibbitz, an Israeli startup that develops technology that automatically turns text into videos, has raised $2.3 million in funding from Hong Kong-based Horizons Ventures – the investment vehicle of billionaire business magnate Li Ka-shing – and prior backers Initial Capital and lool Ventures.

http://thenextweb.com/insider/2012/06/05/wibbitz-turns-text-into-videos-investor-pitches-into-2-3-million-in-funding/

This Week In Venture Capital is brought to you by VM Index from Venture Market Intelligence – Venture Capital made easier

 

VM Index is an online Life Science, Med Tech & Biotech venture capital funding tool with expert data that enables companies to raise more money, faster and at a better valuation than they could otherwise.


Monday 11 June 2012

Life Science Venture Capital Investment News Round Up – 11 June 2012

Highlights from recent Life Science venture capital news.

VM Index subscribers see full details of all Life Science Venture Capital deals from the past week plus profiles and analysis of thousands of investors and venture-backed companies.

 

North America 

June 7th, 2012 - San Diego, CA

Astute Medical Completes $40.4 Million Series C Financing

Astute Medical, Inc., a developer of novel, biomarker-based medical diagnostics, today announced the completion of a $40.4 million Series C financing led by MPM Capital and including new investor Kaiser Permanente Ventures. The Company intends to use the proceeds to begin commercializing its first product, as well as to advance and expand its research, development and validation of biomarker-based laboratory tests. 

http://www.astutemedical.com/news/news060712.php

June 4th, 2012 - Redwood City, CA

SentreHEART Secures $26M Series C Financing

SentreHEART, Inc., a privately-held medical device company announced that it has recently completed a $26 million Series C financing led by Vivo Ventures with participation by its existing investors US Venture Partners and Prospect Ventures.

http://www.sentreheart.com/media/sentreheart-secures-26-million-series-c-financing-commercialization

June 5th, 2012 - Malvern, PA 

PhaseBio Pharmaceuticals Books $23M in Third Tranche of Series B

PhaseBio Pharmaceuticals Inc. said it raised $23 million in additional Series B financing from its investors to support development of drugs to treat diabetes, metabolic disease and cardiovascular disease. The Malvern, Pa., company has now raised $48.4 million from Series B investors, including New Enterprise Associates, which led the round, as well as Astellas Venture Management, Fletcher Spaght Ventures, Hatteras Venture Partners and Johnson & Johnson Development Corp. This is the third tranche of the round, which initially closed in December 2009.

http://pevc.dowjones.com/article?an=DJFVW00020120605e865trtxr&from=alert&pid=32&ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120605e865trtxr%26from%3dalert%26pid%3d32

June 5th, 2012 - Menlo Park, CA

Auxogyn Raises $18M in Series B

Auxogyn, Inc., a privately-held company advancing women’s reproductive health, today announced it raised $18 million through a Series B financing. The financing was led by new investor SR One and includes participation from all Series A investors, Kleiner Perkins Caufield and Byers, TPG Biotech and Merck Serono Ventures. In connection with the financing, Simeon J. George, M.D., partner at SR One, and Nilesh Kumar, Ph.D., director of Merck Serono Ventures, will join the board of directors.

http://www.auxogyn.com/assets/press-releases/2012-06-05.series-b-financing.pdf

June 4th, 2012 - Bridgewater, NJ

Seldar Pharma Raises $13M Series A

Venture-backed Drais Pharmaceuticals Inc. has formed its second partnership with Astellas Pharma Inc. this year, an agreement to transfer an Astellas treatment for irritable bowel syndrome into a new, virtual company that has just raised a $13 million Series A round to develop that drug. InterWest Partners and Sutter Hill Ventures co-led the round for Seldar Pharma Inc., a new company run by Drais management.

http://pevc.dowjones.com/article?an=DJFVW00020120604e864rev6i&from=alert&pid=32&ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120604e864rev6i%26from%3dalert%26pid%3d32

Europe

June 7th, 2012 - Strasbourg, France

ProTip Closes $4.7M Financing

ProTip SA, a Strasbourg, France-based emerging medical device company, has raised $4.7m in Series C financing (approximately €3.8m). The round was led by new investor Seventure, with participation from existing investors Fonds Lorrain des Materiaux (FLM), the Berchet family-office, Alsace Amorcage and other private investors.

http://www.finsmes.com/2012/06/protip-closes-4-7m-financing.html

June 4th, 2012 - Lyon, France

Alize Pharma Closes €3.3M Funding

Alize Pharma, a Lyon, France-based group of companies developing drugs for the treatment of metabolic diseases and cancer, has completed a €3.3m funding round. Backers include existing shareholders Sham, OCTALFA, CEMA Inc., and Thierry Abribat. The company intends to use this capital, which brings the total amount raised to date to €8.3m, to take AZP-531, its UAG (UnAcylated Ghrelin) analog for the treatment of the Prader Willi syndrome and type II diabetes, into Phase I clinical trials.

http://www.finsmes.com/2012/06/alize-pharma-closes-e3-3m-funding.html

This Week In Venture Capital is brought to you by VM Index – Venture Capital made easier

VM Index is an online IT, Life Science, Biotech & Med Tech venture capital funding tool with expert data that enables companies to raise more money, faster and at a better valuation than they could otherwise.


Thursday 7 June 2012

Venture Capital Investment – 7 June 2012

A round up of deal activity in IT, Life Science, Med Tech & Biotech Venture Capital Investment over the past week.

VM Index subscribers see full details of all Venture Capital deals from the past week plus profiles and analysis of thousands of investors and venture-backed companies.


Total No. Deals

NA

EU

Total Raised $

Total Raised €

55

31

24

379.1

303.1

  

North America

  

No. Deals

Total $

Total €

Average $

Average €

31

328.1

262.4

11.7

9.4

  

Europe

 

No. Deals

Total $

Total €

Average $

Average €

24

51.0

40.7

3.9

3.1

 

Breakdown By Sector

 

Life Sciences

  

No. Deals

NA

EU

Total $

Total €

8

5

3

125.9

100.9

Average Deal NA & EU

$

 

21.0

16.8

 

  

Largest Deals

  

Company Name

Region

Stage

$m

€m

Agendia

NA

SVR

65.0

52.2

SpineLab

EU

SVR

4.9

3.9

  

 TMT

 

No. Deals

NA

EU

Total $

Total €

47

26

21

253.2

202.2

Average Deal NA & EU

$

 

7.2

5.8

 

 

Largest Deals

 

Company Name

Region

Stage

$m

€m

10Gen

NA

SVR

42.0

33.4

SenSee

EU

SVR

22.0

17.5

  

This Week In Venture Capital is brought to you by VM Index – Venture Capital made easier

 

VM Index is an online IT, Life Science, Biotech & Med Tech venture capital funding tool with expert data that enables companies to raise more money, faster and at a better valuation than they could otherwise.